nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0776	0.0998	CbGbCtD
Apixaban—ABCG2—Dactinomycin—uterine cancer	0.0765	0.0984	CbGbCtD
Apixaban—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0541	0.0696	CbGbCtD
Apixaban—CYP3A5—Progesterone—uterine cancer	0.0534	0.0688	CbGbCtD
Apixaban—ABCG2—Carboplatin—uterine cancer	0.0514	0.0662	CbGbCtD
Apixaban—CYP2C8—Progesterone—uterine cancer	0.0514	0.0661	CbGbCtD
Apixaban—ABCG2—Etoposide—uterine cancer	0.0432	0.0555	CbGbCtD
Apixaban—CYP2C19—Progesterone—uterine cancer	0.0431	0.0555	CbGbCtD
Apixaban—CYP1A2—Progesterone—uterine cancer	0.0398	0.0512	CbGbCtD
Apixaban—CYP2C9—Progesterone—uterine cancer	0.0358	0.0461	CbGbCtD
Apixaban—ABCB1—Progesterone—uterine cancer	0.0348	0.0448	CbGbCtD
Apixaban—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0315	0.0405	CbGbCtD
Apixaban—ABCG2—Doxorubicin—uterine cancer	0.0294	0.0379	CbGbCtD
Apixaban—ABCB1—Dactinomycin—uterine cancer	0.0276	0.0355	CbGbCtD
Apixaban—Genital haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.0248	0.175	CcSEcCtD
Apixaban—CYP3A5—Etoposide—uterine cancer	0.0239	0.0308	CbGbCtD
Apixaban—CYP2C8—Etoposide—uterine cancer	0.023	0.0296	CbGbCtD
Apixaban—CYP3A4—Progesterone—uterine cancer	0.0208	0.0268	CbGbCtD
Apixaban—CYP1A2—Etoposide—uterine cancer	0.0178	0.0229	CbGbCtD
Apixaban—ABCB1—Etoposide—uterine cancer	0.0156	0.02	CbGbCtD
Apixaban—Menometrorrhagia—Medroxyprogesterone Acetate—uterine cancer	0.013	0.0916	CcSEcCtD
Apixaban—ABCB1—Doxorubicin—uterine cancer	0.0106	0.0137	CbGbCtD
Apixaban—CYP3A4—Etoposide—uterine cancer	0.00933	0.012	CbGbCtD
Apixaban—CYP2J2—artery—uterine cancer	0.0064	0.116	CbGeAlD
Apixaban—CYP3A4—Doxorubicin—uterine cancer	0.00636	0.00819	CbGbCtD
Apixaban—F10—uterine cervix—uterine cancer	0.00294	0.0531	CbGeAlD
Apixaban—F10—decidua—uterine cancer	0.0028	0.0506	CbGeAlD
Apixaban—Transaminases increased—Progesterone—uterine cancer	0.00271	0.0192	CcSEcCtD
Apixaban—Cerebral haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.0027	0.0191	CcSEcCtD
Apixaban—F10—endometrium—uterine cancer	0.00266	0.048	CbGeAlD
Apixaban—F10—mammalian vulva—uterine cancer	0.00257	0.0465	CbGeAlD
Apixaban—Metrorrhagia—Progesterone—uterine cancer	0.00231	0.0163	CcSEcCtD
Apixaban—Menorrhagia—Progesterone—uterine cancer	0.00223	0.0157	CcSEcCtD
Apixaban—Vaginal haemorrhage—Progesterone—uterine cancer	0.00223	0.0157	CcSEcCtD
Apixaban—F10—female reproductive system—uterine cancer	0.0022	0.0398	CbGeAlD
Apixaban—CYP2J2—endometrium—uterine cancer	0.00218	0.0394	CbGeAlD
Apixaban—CYP2J2—mammalian vulva—uterine cancer	0.0021	0.0381	CbGeAlD
Apixaban—Metrorrhagia—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.0148	CcSEcCtD
Apixaban—Menorrhagia—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.0143	CcSEcCtD
Apixaban—Vaginal haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.0143	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Progesterone—uterine cancer	0.00201	0.0142	CcSEcCtD
Apixaban—CYP2J2—uterus—uterine cancer	0.00201	0.0363	CbGeAlD
Apixaban—F10—female gonad—uterine cancer	0.002	0.0362	CbGeAlD
Apixaban—F10—vagina—uterine cancer	0.00199	0.036	CbGeAlD
Apixaban—CYP2J2—female reproductive system—uterine cancer	0.0018	0.0326	CbGeAlD
Apixaban—Rectal haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0117	CcSEcCtD
Apixaban—CYP2J2—vagina—uterine cancer	0.00163	0.0295	CbGeAlD
Apixaban—F10—lymph node—uterine cancer	0.00129	0.0233	CbGeAlD
Apixaban—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00881	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00881	CcSEcCtD
Apixaban—Drug hypersensitivity—Epirubicin—uterine cancer	0.00117	0.0083	CcSEcCtD
Apixaban—Haematochezia—Epirubicin—uterine cancer	0.00117	0.0083	CcSEcCtD
Apixaban—ABCG2—myometrium—uterine cancer	0.00117	0.0212	CbGeAlD
Apixaban—Liver function test abnormal—Progesterone—uterine cancer	0.00111	0.00781	CcSEcCtD
Apixaban—Drug hypersensitivity—Doxorubicin—uterine cancer	0.00109	0.00768	CcSEcCtD
Apixaban—Haematochezia—Doxorubicin—uterine cancer	0.00109	0.00768	CcSEcCtD
Apixaban—Breast disorder—Progesterone—uterine cancer	0.00108	0.00764	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00108	0.00762	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00106	0.00746	CcSEcCtD
Apixaban—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.000981	0.00693	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.000957	0.00676	CcSEcCtD
Apixaban—ABCG2—uterine cervix—uterine cancer	0.000912	0.0165	CbGeAlD
Apixaban—CYP2C8—renal system—uterine cancer	0.000878	0.0159	CbGeAlD
Apixaban—Hepatobiliary disease—Progesterone—uterine cancer	0.000873	0.00617	CcSEcCtD
Apixaban—ABCG2—decidua—uterine cancer	0.000869	0.0157	CbGeAlD
Apixaban—CYP2C8—endometrium—uterine cancer	0.000849	0.0153	CbGeAlD
Apixaban—CYP3A5—uterine cervix—uterine cancer	0.000847	0.0153	CbGeAlD
Apixaban—Gingival bleeding—Epirubicin—uterine cancer	0.000834	0.00589	CcSEcCtD
Apixaban—Haemoglobin—Progesterone—uterine cancer	0.000833	0.00588	CcSEcCtD
Apixaban—Haemorrhage—Progesterone—uterine cancer	0.000829	0.00585	CcSEcCtD
Apixaban—ABCG2—endometrium—uterine cancer	0.000825	0.0149	CbGeAlD
Apixaban—CYP1A2—renal system—uterine cancer	0.000821	0.0149	CbGeAlD
Apixaban—Urinary tract disorder—Progesterone—uterine cancer	0.000818	0.00578	CcSEcCtD
Apixaban—Connective tissue disorder—Progesterone—uterine cancer	0.000814	0.00575	CcSEcCtD
Apixaban—Urethral disorder—Progesterone—uterine cancer	0.000812	0.00574	CcSEcCtD
Apixaban—ABCG2—mammalian vulva—uterine cancer	0.000798	0.0144	CbGeAlD
Apixaban—CYP3A5—renal system—uterine cancer	0.000792	0.0143	CbGeAlD
Apixaban—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.000791	0.00559	CcSEcCtD
Apixaban—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.000789	0.00557	CcSEcCtD
Apixaban—Liver function test abnormal—Dactinomycin—uterine cancer	0.000782	0.00552	CcSEcCtD
Apixaban—Transaminases increased—Epirubicin—uterine cancer	0.000778	0.00549	CcSEcCtD
Apixaban—Eye disorder—Progesterone—uterine cancer	0.000774	0.00547	CcSEcCtD
Apixaban—Gingival bleeding—Doxorubicin—uterine cancer	0.000772	0.00545	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.000762	0.00538	CcSEcCtD
Apixaban—ABCG2—uterus—uterine cancer	0.00076	0.0138	CbGeAlD
Apixaban—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000755	0.00533	CcSEcCtD
Apixaban—Angiopathy—Progesterone—uterine cancer	0.000752	0.00531	CcSEcCtD
Apixaban—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000751	0.0053	CcSEcCtD
Apixaban—Immune system disorder—Progesterone—uterine cancer	0.000748	0.00529	CcSEcCtD
Apixaban—Mediastinal disorder—Progesterone—uterine cancer	0.000747	0.00527	CcSEcCtD
Apixaban—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.000742	0.00524	CcSEcCtD
Apixaban—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.000738	0.00521	CcSEcCtD
Apixaban—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.000736	0.0052	CcSEcCtD
Apixaban—CYP2C19—vagina—uterine cancer	0.000728	0.0132	CbGeAlD
Apixaban—Transaminases increased—Doxorubicin—uterine cancer	0.00072	0.00508	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.000704	0.00498	CcSEcCtD
Apixaban—CYP2C8—female reproductive system—uterine cancer	0.000703	0.0127	CbGeAlD
Apixaban—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.000702	0.00496	CcSEcCtD
Apixaban—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000681	0.00481	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—uterine cancer	0.000681	0.00481	CcSEcCtD
Apixaban—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000678	0.00479	CcSEcCtD
Apixaban—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00478	CcSEcCtD
Apixaban—Anaemia—Progesterone—uterine cancer	0.000667	0.00471	CcSEcCtD
Apixaban—Syncope—Progesterone—uterine cancer	0.000647	0.00457	CcSEcCtD
Apixaban—Haemoptysis—Epirubicin—uterine cancer	0.000639	0.00452	CcSEcCtD
Apixaban—Vaginal haemorrhage—Epirubicin—uterine cancer	0.000639	0.00452	CcSEcCtD
Apixaban—CYP2C8—vagina—uterine cancer	0.000636	0.0115	CbGeAlD
Apixaban—Loss of consciousness—Progesterone—uterine cancer	0.000634	0.00448	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—uterine cancer	0.00063	0.00445	CcSEcCtD
Apixaban—CYP2C9—female reproductive system—uterine cancer	0.000624	0.0113	CbGeAlD
Apixaban—ABCG2—female gonad—uterine cancer	0.000622	0.0112	CbGeAlD
Apixaban—ABCG2—vagina—uterine cancer	0.000618	0.0112	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00061	0.00431	CcSEcCtD
Apixaban—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000604	0.00427	CcSEcCtD
Apixaban—CYP3A4—renal system—uterine cancer	0.000595	0.0108	CbGeAlD
Apixaban—Vaginal haemorrhage—Doxorubicin—uterine cancer	0.000592	0.00418	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—uterine cancer	0.000592	0.00418	CcSEcCtD
Apixaban—Anaphylactic shock—Progesterone—uterine cancer	0.000589	0.00416	CcSEcCtD
Apixaban—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00414	CcSEcCtD
Apixaban—Shock—Progesterone—uterine cancer	0.000579	0.00409	CcSEcCtD
Apixaban—ABCB1—myometrium—uterine cancer	0.000578	0.0105	CbGeAlD
Apixaban—Nervous system disorder—Progesterone—uterine cancer	0.000577	0.00408	CcSEcCtD
Apixaban—CYP3A5—female gonad—uterine cancer	0.000577	0.0104	CbGeAlD
Apixaban—Petechiae—Epirubicin—uterine cancer	0.000575	0.00406	CcSEcCtD
Apixaban—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00406	CcSEcCtD
Apixaban—CYP3A5—vagina—uterine cancer	0.000574	0.0104	CbGeAlD
Apixaban—Skin disorder—Progesterone—uterine cancer	0.000572	0.00404	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000553	0.0039	CcSEcCtD
Apixaban—Hypotension—Progesterone—uterine cancer	0.00055	0.00389	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00054	0.00382	CcSEcCtD
Apixaban—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000533	0.00377	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—uterine cancer	0.000532	0.00376	CcSEcCtD
Apixaban—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000525	0.00371	CcSEcCtD
Apixaban—Rectal haemorrhage—Epirubicin—uterine cancer	0.000524	0.0037	CcSEcCtD
Apixaban—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000523	0.00369	CcSEcCtD
Apixaban—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000522	0.00369	CcSEcCtD
Apixaban—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000518	0.00366	CcSEcCtD
Apixaban—Gastrointestinal disorder—Progesterone—uterine cancer	0.000508	0.00359	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—uterine cancer	0.0005	0.00353	CcSEcCtD
Apixaban—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000498	0.00352	CcSEcCtD
Apixaban—Rectal haemorrhage—Doxorubicin—uterine cancer	0.000485	0.00342	CcSEcCtD
Apixaban—CYP3A4—female reproductive system—uterine cancer	0.000476	0.00861	CbGeAlD
Apixaban—Anaemia—Dactinomycin—uterine cancer	0.000471	0.00333	CcSEcCtD
Apixaban—Blood bilirubin increased—Doxorubicin—uterine cancer	0.000463	0.00327	CcSEcCtD
Apixaban—Melaena—Epirubicin—uterine cancer	0.000462	0.00326	CcSEcCtD
Apixaban—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.00325	CcSEcCtD
Apixaban—ABCB1—epithelium—uterine cancer	0.000454	0.00821	CbGeAlD
Apixaban—ABCB1—uterine cervix—uterine cancer	0.00045	0.00814	CbGeAlD
Apixaban—Hepatobiliary disease—Etoposide—uterine cancer	0.000447	0.00315	CcSEcCtD
Apixaban—Hypersensitivity—Progesterone—uterine cancer	0.000434	0.00306	CcSEcCtD
Apixaban—ABCB1—decidua—uterine cancer	0.000429	0.00775	CbGeAlD
Apixaban—Ecchymosis—Epirubicin—uterine cancer	0.000428	0.00302	CcSEcCtD
Apixaban—Melaena—Doxorubicin—uterine cancer	0.000428	0.00302	CcSEcCtD
Apixaban—ABCB1—renal system—uterine cancer	0.000421	0.00761	CbGeAlD
Apixaban—Urinary tract disorder—Etoposide—uterine cancer	0.000419	0.00296	CcSEcCtD
Apixaban—Urethral disorder—Etoposide—uterine cancer	0.000416	0.00293	CcSEcCtD
Apixaban—Thrombocytopenia—Dactinomycin—uterine cancer	0.000407	0.00288	CcSEcCtD
Apixaban—ABCB1—endometrium—uterine cancer	0.000407	0.00736	CbGeAlD
Apixaban—ABCG2—lymph node—uterine cancer	0.0004	0.00723	CbGeAlD
Apixaban—Eye disorder—Etoposide—uterine cancer	0.000396	0.0028	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—uterine cancer	0.000396	0.0028	CcSEcCtD
Apixaban—Diabetes mellitus—Epirubicin—uterine cancer	0.000395	0.00279	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000395	0.00279	CcSEcCtD
Apixaban—ABCB1—mammalian vulva—uterine cancer	0.000394	0.00712	CbGeAlD
Apixaban—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.00278	CcSEcCtD
Apixaban—Dizziness—Progesterone—uterine cancer	0.000389	0.00275	CcSEcCtD
Apixaban—Angiopathy—Etoposide—uterine cancer	0.000385	0.00272	CcSEcCtD
Apixaban—Immune system disorder—Etoposide—uterine cancer	0.000383	0.0027	CcSEcCtD
Apixaban—Mediastinal disorder—Etoposide—uterine cancer	0.000382	0.0027	CcSEcCtD
Apixaban—ABCB1—uterus—uterine cancer	0.000375	0.00678	CbGeAlD
Apixaban—Rash—Progesterone—uterine cancer	0.000371	0.00262	CcSEcCtD
Apixaban—Dermatitis—Progesterone—uterine cancer	0.000371	0.00262	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000365	0.00258	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—uterine cancer	0.000365	0.00258	CcSEcCtD
Apixaban—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00249	CcSEcCtD
Apixaban—Nausea—Progesterone—uterine cancer	0.00035	0.00247	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000343	0.00243	CcSEcCtD
Apixaban—Anaemia—Etoposide—uterine cancer	0.000341	0.00241	CcSEcCtD
Apixaban—ABCB1—female reproductive system—uterine cancer	0.000337	0.0061	CbGeAlD
Apixaban—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000336	0.00238	CcSEcCtD
Apixaban—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000336	0.00237	CcSEcCtD
Apixaban—Loss of consciousness—Etoposide—uterine cancer	0.000324	0.00229	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000318	0.00224	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—uterine cancer	0.000317	0.00224	CcSEcCtD
Apixaban—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000317	0.00224	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000312	0.0022	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—uterine cancer	0.00031	0.00219	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000309	0.00218	CcSEcCtD
Apixaban—ABCB1—female gonad—uterine cancer	0.000307	0.00555	CbGeAlD
Apixaban—Hypersensitivity—Dactinomycin—uterine cancer	0.000307	0.00217	CcSEcCtD
Apixaban—ABCB1—vagina—uterine cancer	0.000305	0.00551	CbGeAlD
Apixaban—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000303	0.00214	CcSEcCtD
Apixaban—Anaphylactic shock—Etoposide—uterine cancer	0.000301	0.00213	CcSEcCtD
Apixaban—Thrombocytopenia—Etoposide—uterine cancer	0.000295	0.00208	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—uterine cancer	0.000293	0.00207	CcSEcCtD
Apixaban—Skin disorder—Etoposide—uterine cancer	0.000293	0.00207	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—uterine cancer	0.000287	0.00203	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000286	0.00202	CcSEcCtD
Apixaban—Hypotension—Etoposide—uterine cancer	0.000281	0.00199	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00028	0.00198	CcSEcCtD
Apixaban—Rash—Dactinomycin—uterine cancer	0.000262	0.00185	CcSEcCtD
Apixaban—Gastrointestinal disorder—Etoposide—uterine cancer	0.00026	0.00184	CcSEcCtD
Apixaban—Haematuria—Epirubicin—uterine cancer	0.000252	0.00178	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—uterine cancer	0.00025	0.00177	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—uterine cancer	0.00025	0.00176	CcSEcCtD
Apixaban—Nausea—Dactinomycin—uterine cancer	0.000247	0.00175	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—uterine cancer	0.000239	0.00169	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—uterine cancer	0.000238	0.00168	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—uterine cancer	0.000235	0.00166	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—uterine cancer	0.000234	0.00165	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—uterine cancer	0.000233	0.00165	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—uterine cancer	0.000233	0.00165	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000232	0.00164	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—uterine cancer	0.000231	0.00163	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—uterine cancer	0.000222	0.00157	CcSEcCtD
Apixaban—Hypersensitivity—Etoposide—uterine cancer	0.000222	0.00157	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—uterine cancer	0.000221	0.00156	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—uterine cancer	0.00022	0.00155	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—uterine cancer	0.000217	0.00153	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—uterine cancer	0.000216	0.00153	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—uterine cancer	0.000216	0.00152	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—uterine cancer	0.000216	0.00152	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—uterine cancer	0.000215	0.00152	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—uterine cancer	0.000214	0.00151	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—uterine cancer	0.000205	0.00145	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—uterine cancer	0.000199	0.00141	CcSEcCtD
Apixaban—Dizziness—Etoposide—uterine cancer	0.000199	0.00141	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—uterine cancer	0.000199	0.0014	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—uterine cancer	0.000198	0.0014	CcSEcCtD
Apixaban—ABCB1—lymph node—uterine cancer	0.000197	0.00357	CbGeAlD
Apixaban—Anaemia—Epirubicin—uterine cancer	0.000191	0.00135	CcSEcCtD
Apixaban—Rash—Etoposide—uterine cancer	0.00019	0.00134	CcSEcCtD
Apixaban—Dermatitis—Etoposide—uterine cancer	0.00019	0.00134	CcSEcCtD
Apixaban—Syncope—Epirubicin—uterine cancer	0.000185	0.00131	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—uterine cancer	0.000182	0.00128	CcSEcCtD
Apixaban—Nausea—Etoposide—uterine cancer	0.000179	0.00126	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—uterine cancer	0.000177	0.00125	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000175	0.00124	CcSEcCtD
Apixaban—Syncope—Doxorubicin—uterine cancer	0.000172	0.00121	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—uterine cancer	0.000169	0.00119	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—uterine cancer	0.000168	0.00119	CcSEcCtD
Apixaban—Shock—Epirubicin—uterine cancer	0.000166	0.00117	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—uterine cancer	0.000166	0.00117	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—uterine cancer	0.000165	0.00117	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—uterine cancer	0.000164	0.00116	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000162	0.00114	CcSEcCtD
Apixaban—Hypotension—Epirubicin—uterine cancer	0.000158	0.00111	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—uterine cancer	0.000156	0.0011	CcSEcCtD
Apixaban—Shock—Doxorubicin—uterine cancer	0.000154	0.00109	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—uterine cancer	0.000153	0.00108	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—uterine cancer	0.000153	0.00108	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—uterine cancer	0.000152	0.00107	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—uterine cancer	0.000146	0.00103	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000146	0.00103	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000135	0.000952	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—uterine cancer	0.000124	0.000878	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—uterine cancer	0.000115	0.000813	CcSEcCtD
Apixaban—Dizziness—Epirubicin—uterine cancer	0.000112	0.000788	CcSEcCtD
Apixaban—Rash—Epirubicin—uterine cancer	0.000106	0.000752	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—uterine cancer	0.000106	0.000751	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—uterine cancer	0.000103	0.00073	CcSEcCtD
Apixaban—Nausea—Epirubicin—uterine cancer	0.0001	0.000708	CcSEcCtD
Apixaban—Rash—Doxorubicin—uterine cancer	9.85e-05	0.000696	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—uterine cancer	9.84e-05	0.000695	CcSEcCtD
Apixaban—Nausea—Doxorubicin—uterine cancer	9.28e-05	0.000655	CcSEcCtD
Apixaban—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	5.35e-05	0.00206	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—RRM2—uterine cancer	5.29e-05	0.00203	CbGpPWpGaD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.25e-05	0.00202	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	5.22e-05	0.00201	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	5.19e-05	0.002	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—DCN—uterine cancer	5.13e-05	0.00197	CbGpPWpGaD
Apixaban—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	5.12e-05	0.00197	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.1e-05	0.00196	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	4.94e-05	0.0019	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	4.91e-05	0.00189	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	4.84e-05	0.00186	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CYP11A1—uterine cancer	4.84e-05	0.00186	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	4.71e-05	0.00181	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	4.71e-05	0.00181	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	4.64e-05	0.00178	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	4.59e-05	0.00176	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.58e-05	0.00176	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	4.57e-05	0.00176	CbGpPWpGaD
Apixaban—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	4.57e-05	0.00176	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKR1C3—uterine cancer	4.57e-05	0.00176	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.53e-05	0.00174	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.53e-05	0.00174	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NDUFB11—uterine cancer	4.5e-05	0.00173	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—SRD5A2—uterine cancer	4.5e-05	0.00173	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.36e-05	0.00168	CbGpPWpGaD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.34e-05	0.00167	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	4.23e-05	0.00163	CbGpPWpGaD
Apixaban—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	4.17e-05	0.0016	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.16e-05	0.0016	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	4.14e-05	0.00159	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	4.14e-05	0.00159	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CCL2—uterine cancer	4.12e-05	0.00159	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.04e-05	0.00155	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.04e-05	0.00155	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	4.03e-05	0.00155	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CXCL8—uterine cancer	3.92e-05	0.00151	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.92e-05	0.00151	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.88e-05	0.00149	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.87e-05	0.00149	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.79e-05	0.00146	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.75e-05	0.00144	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.74e-05	0.00144	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.73e-05	0.00143	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.69e-05	0.00142	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.69e-05	0.00142	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.68e-05	0.00141	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	3.61e-05	0.00139	CbGpPWpGaD
Apixaban—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	3.56e-05	0.00137	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—STK11—uterine cancer	3.56e-05	0.00137	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CYP19A1—uterine cancer	3.56e-05	0.00137	CbGpPWpGaD
Apixaban—F10—Hemostasis—EP300—uterine cancer	3.55e-05	0.00137	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.53e-05	0.00136	CbGpPWpGaD
Apixaban—F10—Hemostasis—VEGFA—uterine cancer	3.37e-05	0.00129	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.34e-05	0.00128	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	3.33e-05	0.00128	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.33e-05	0.00128	CbGpPWpGaD
Apixaban—F10—Hemostasis—NRAS—uterine cancer	3.33e-05	0.00128	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CXCL8—uterine cancer	3.26e-05	0.00125	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKR1B1—uterine cancer	3.25e-05	0.00125	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—STAR—uterine cancer	3.25e-05	0.00125	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NDUFB11—uterine cancer	3.22e-05	0.00124	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—SRD5A2—uterine cancer	3.22e-05	0.00124	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.19e-05	0.00122	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—VEGFA—uterine cancer	3.18e-05	0.00122	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.15e-05	0.00121	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.15e-05	0.00121	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CTNNB1—uterine cancer	3.01e-05	0.00116	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.97e-05	0.00114	CbGpPWpGaD
Apixaban—F10—Hemostasis—KRAS—uterine cancer	2.86e-05	0.0011	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.83e-05	0.00109	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.79e-05	0.00107	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.79e-05	0.00107	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.79e-05	0.00107	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.78e-05	0.00107	CbGpPWpGaD
Apixaban—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.75e-05	0.00106	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.71e-05	0.00104	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.71e-05	0.00104	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—MTHFR—uterine cancer	2.67e-05	0.00103	CbGpPWpGaD
Apixaban—F10—Hemostasis—PIK3CA—uterine cancer	2.63e-05	0.00101	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.56e-05	0.000984	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—POLD1—uterine cancer	2.55e-05	0.000981	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—uterine cancer	2.54e-05	0.000978	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.49e-05	0.000958	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.49e-05	0.000958	CbGpPWpGaD
Apixaban—F10—Hemostasis—HRAS—uterine cancer	2.43e-05	0.000935	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SRD5A2—uterine cancer	2.43e-05	0.000935	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NDUFB11—uterine cancer	2.43e-05	0.000935	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.42e-05	0.00093	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKR1C1—uterine cancer	2.39e-05	0.000918	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.36e-05	0.000906	CbGpPWpGaD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.35e-05	0.000902	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—STAR—uterine cancer	2.33e-05	0.000896	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKR1B1—uterine cancer	2.33e-05	0.000896	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.31e-05	0.000889	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.29e-05	0.000879	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.27e-05	0.000873	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.27e-05	0.000873	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.21e-05	0.000848	CbGpPWpGaD
Apixaban—F10—Hemostasis—AKT1—uterine cancer	2.15e-05	0.000826	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—RRM2—uterine cancer	2.13e-05	0.000818	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.08e-05	0.000801	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—DCN—uterine cancer	2.07e-05	0.000794	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.04e-05	0.000784	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.02e-05	0.000776	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—STAR—uterine cancer	2.02e-05	0.000776	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.99e-05	0.000767	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP11A1—uterine cancer	1.95e-05	0.000748	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.94e-05	0.000746	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.94e-05	0.000746	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.89e-05	0.000726	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.89e-05	0.000725	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKR1C3—uterine cancer	1.84e-05	0.000706	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—POLD1—uterine cancer	1.83e-05	0.000703	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.8e-05	0.000692	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—STAR—uterine cancer	1.8e-05	0.000692	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.79e-05	0.000686	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.78e-05	0.000685	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.78e-05	0.000684	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKR1B1—uterine cancer	1.76e-05	0.000676	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—STAR—uterine cancer	1.76e-05	0.000676	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.74e-05	0.000669	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.71e-05	0.000657	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.66e-05	0.000638	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—STAR—uterine cancer	1.64e-05	0.000631	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.64e-05	0.000631	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.62e-05	0.000624	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—POLD1—uterine cancer	1.58e-05	0.000609	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.57e-05	0.000604	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—RRM2—uterine cancer	1.52e-05	0.000586	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.5e-05	0.000576	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.5e-05	0.000576	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTEN—uterine cancer	1.49e-05	0.000572	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.48e-05	0.000569	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—DCN—uterine cancer	1.48e-05	0.000569	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—STK11—uterine cancer	1.43e-05	0.00055	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CYP19A1—uterine cancer	1.43e-05	0.00055	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—EP300—uterine cancer	1.42e-05	0.000545	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—POLD1—uterine cancer	1.41e-05	0.000543	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.4e-05	0.00054	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—STAR—uterine cancer	1.4e-05	0.00054	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.39e-05	0.000536	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.39e-05	0.000533	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—POLD1—uterine cancer	1.38e-05	0.00053	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.34e-05	0.000514	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.32e-05	0.000508	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—RRM2—uterine cancer	1.32e-05	0.000508	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.32e-05	0.000506	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKR1C1—uterine cancer	1.29e-05	0.000496	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—POLD1—uterine cancer	1.29e-05	0.000495	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—DCN—uterine cancer	1.28e-05	0.000493	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.23e-05	0.000472	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.21e-05	0.000464	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.21e-05	0.000463	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.19e-05	0.000456	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—RRM2—uterine cancer	1.18e-05	0.000453	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—RRM2—uterine cancer	1.15e-05	0.000442	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—DCN—uterine cancer	1.14e-05	0.00044	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.14e-05	0.000438	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—DCN—uterine cancer	1.12e-05	0.000429	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—POLD1—uterine cancer	1.1e-05	0.000423	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.08e-05	0.000416	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—STAR—uterine cancer	1.08e-05	0.000416	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.08e-05	0.000414	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MTHFR—uterine cancer	1.08e-05	0.000414	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—RRM2—uterine cancer	1.07e-05	0.000413	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP11A1—uterine cancer	1.05e-05	0.000404	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—uterine cancer	1.05e-05	0.000403	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—DCN—uterine cancer	1.04e-05	0.000401	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.03e-05	0.000396	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—STK11—uterine cancer	1.03e-05	0.000394	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.03e-05	0.000394	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.02e-05	0.000391	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1e-05	0.000385	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKR1C3—uterine cancer	9.93e-06	0.000382	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP11A1—uterine cancer	9.83e-06	0.000378	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKR1C3—uterine cancer	9.28e-06	0.000357	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—RRM2—uterine cancer	9.18e-06	0.000353	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—DCN—uterine cancer	8.91e-06	0.000343	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—STK11—uterine cancer	8.88e-06	0.000342	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYP19A1—uterine cancer	8.88e-06	0.000342	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—uterine cancer	8.57e-06	0.00033	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—POLD1—uterine cancer	8.5e-06	0.000327	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP11A1—uterine cancer	8.4e-06	0.000323	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.34e-06	0.000321	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.95e-06	0.000306	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKR1C1—uterine cancer	7.95e-06	0.000306	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKR1C3—uterine cancer	7.93e-06	0.000305	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—STK11—uterine cancer	7.93e-06	0.000305	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP19A1—uterine cancer	7.93e-06	0.000305	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—STK11—uterine cancer	7.74e-06	0.000298	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP19A1—uterine cancer	7.74e-06	0.000298	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—uterine cancer	7.71e-06	0.000296	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.44e-06	0.000286	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP19A1—uterine cancer	7.23e-06	0.000278	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—STK11—uterine cancer	7.23e-06	0.000278	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.1e-06	0.000273	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—RRM2—uterine cancer	7.09e-06	0.000272	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—DCN—uterine cancer	6.88e-06	0.000264	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.79e-06	0.000261	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—uterine cancer	6.68e-06	0.000257	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.48e-06	0.000249	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.47e-06	0.000249	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—STK11—uterine cancer	6.18e-06	0.000238	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP19A1—uterine cancer	6.18e-06	0.000238	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.12e-06	0.000235	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTEN—uterine cancer	5.98e-06	0.00023	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—uterine cancer	5.96e-06	0.000229	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.88e-06	0.000226	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—uterine cancer	5.82e-06	0.000224	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.8e-06	0.000223	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—EP300—uterine cancer	5.71e-06	0.000219	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.53e-06	0.000213	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—uterine cancer	5.43e-06	0.000209	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.25e-06	0.000202	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.79e-06	0.000184	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—STK11—uterine cancer	4.77e-06	0.000183	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.77e-06	0.000183	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—uterine cancer	4.64e-06	0.000178	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTEN—uterine cancer	4.29e-06	0.000165	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—uterine cancer	4.22e-06	0.000162	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.09e-06	0.000157	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—EP300—uterine cancer	4.09e-06	0.000157	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTEN—uterine cancer	3.71e-06	0.000143	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—uterine cancer	3.58e-06	0.000138	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—EP300—uterine cancer	3.54e-06	0.000136	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—uterine cancer	3.45e-06	0.000133	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTEN—uterine cancer	3.31e-06	0.000127	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTEN—uterine cancer	3.24e-06	0.000124	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—EP300—uterine cancer	3.16e-06	0.000122	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—EP300—uterine cancer	3.09e-06	0.000119	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.02e-06	0.000116	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTEN—uterine cancer	3.02e-06	0.000116	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—EP300—uterine cancer	2.88e-06	0.000111	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.62e-06	0.000101	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTEN—uterine cancer	2.58e-06	9.93e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—uterine cancer	2.47e-06	9.5e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—EP300—uterine cancer	2.46e-06	9.47e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.34e-06	8.99e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—uterine cancer	2.28e-06	8.77e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—uterine cancer	2.14e-06	8.23e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.13e-06	8.2e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTEN—uterine cancer	1.99e-06	7.66e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—uterine cancer	1.91e-06	7.34e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—EP300—uterine cancer	1.9e-06	7.31e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—uterine cancer	1.86e-06	7.17e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.82e-06	7e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—uterine cancer	1.74e-06	6.7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—uterine cancer	1.49e-06	5.72e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.41e-06	5.41e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—uterine cancer	1.15e-06	4.42e-05	CbGpPWpGaD
